Hypercholesterolemia: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (subpages) |
imported>Robert Badgett |
||
| Line 3: | Line 3: | ||
==Treatment== | ==Treatment== | ||
[[Statin]] therapy | [[Statin]] therapy prevents major vascular events in about 1 of every 24 patients with [[diabetes]] who use the treatment for 5 years if they are similar to the patients in the [[meta-analysis]] by Kearney et al ([[Number needed to treat]] is 24).<ref name="pmid18191683">{{cite journal |author=Kearney PM, Blackwell L, Collins R, ''et al'' |title=Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis |journal=Lancet |volume=371 |issue=9607 |pages=117–25 |year=2008 |pmid=18191683 |doi=10.1016/S0140-6736(08)60104-X}}</ref> | ||
===Primary prevention=== | |||
<!-- see http://www.nytimes.com/2008/01/29/health/29well.html --> | |||
Overall mortality is ''insignificantly'' reduced from 6.6% over 4.3 years to 6.1% in patients without prior cardiovascular disease ([[Number needed to treat]], although statistically insignificant, is estimated to be 200).<ref name="pmid17130382">{{cite journal |author=Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK |title=Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials |journal=Arch. Intern. Med. |volume=166 |issue=21 |pages=2307–13 |year=2006 |pmid=17130382 |doi=10.1001/archinte.166.21.2307}}</ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 02:21, 29 January 2008
Hypercolesterolemia is "a condition with abnormally high levels of cholesterol in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population."[1]
Treatment
Statin therapy prevents major vascular events in about 1 of every 24 patients with diabetes who use the treatment for 5 years if they are similar to the patients in the meta-analysis by Kearney et al (Number needed to treat is 24).[2]
Primary prevention
Overall mortality is insignificantly reduced from 6.6% over 4.3 years to 6.1% in patients without prior cardiovascular disease (Number needed to treat, although statistically insignificant, is estimated to be 200).[3]
References
- ↑ Anonymous. Hypercholesterolemia. National Library of Medicine. Retrieved on 2008-01-18.
- ↑ Kearney PM, Blackwell L, Collins R, et al (2008). "Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis". Lancet 371 (9607): 117–25. DOI:10.1016/S0140-6736(08)60104-X. PMID 18191683. Research Blogging.
- ↑ Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK (2006). "Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials". Arch. Intern. Med. 166 (21): 2307–13. DOI:10.1001/archinte.166.21.2307. PMID 17130382. Research Blogging.